OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Testing for GW501516 (cardarine) in human hair using LC/MS–MS and confirmation by LC/HRMS
Pascal Kintz, Alice Ameline, Laurie Gheddar, et al.
Drug Testing and Analysis (2020) Vol. 12, Iss. 7, pp. 980-986
Closed Access | Times Cited: 22
Pascal Kintz, Alice Ameline, Laurie Gheddar, et al.
Drug Testing and Analysis (2020) Vol. 12, Iss. 7, pp. 980-986
Closed Access | Times Cited: 22
Showing 22 citing articles:
Annual banned‐substance review: Analytical approaches in human sports drug testing 2019/2020
Mario Thevis, Tiia Kuuranne, Hans Geyer
Drug Testing and Analysis (2020) Vol. 13, Iss. 1, pp. 8-35
Open Access | Times Cited: 29
Mario Thevis, Tiia Kuuranne, Hans Geyer
Drug Testing and Analysis (2020) Vol. 13, Iss. 1, pp. 8-35
Open Access | Times Cited: 29
Targeting Energy Expenditure—Drugs for Obesity Treatment
Carlos M. Jimenez-Muñoz, M. Allué López, Fernando Alberício, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 5, pp. 435-435
Open Access | Times Cited: 27
Carlos M. Jimenez-Muñoz, M. Allué López, Fernando Alberício, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 5, pp. 435-435
Open Access | Times Cited: 27
Novel Solid Forms of Cardarine/GW501516 and Their Characterization by X-Ray Diffraction, Thermal, Computational, FTIR, and UV Analysis
Alexandru Turza, Maria Boşca, Marieta Mureșan-Pop, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 152-152
Open Access
Alexandru Turza, Maria Boşca, Marieta Mureșan-Pop, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 152-152
Open Access
Cannabinoids and PPAR Ligands: The Future in Treatment of Polycystic Ovary Syndrome Women with Obesity and Reduced Fertility
Piotr Przybycień, Danuta Gąsior‐Perczak, Wojciech Placha
Cells (2022) Vol. 11, Iss. 16, pp. 2569-2569
Open Access | Times Cited: 16
Piotr Przybycień, Danuta Gąsior‐Perczak, Wojciech Placha
Cells (2022) Vol. 11, Iss. 16, pp. 2569-2569
Open Access | Times Cited: 16
Five Novel Polymorphs of Cardarine/GW501516 and Their Characterization by X-ray Diffraction, Computational Methods, Thermal Analysis and a Pharmaceutical Perspective
Alexandru Turza, Petru Păşcuţă, Marieta Muresan‐Pop, et al.
Pharmaceutics (2024) Vol. 16, Iss. 5, pp. 623-623
Open Access | Times Cited: 3
Alexandru Turza, Petru Păşcuţă, Marieta Muresan‐Pop, et al.
Pharmaceutics (2024) Vol. 16, Iss. 5, pp. 623-623
Open Access | Times Cited: 3
Peroxisome Proliferator-Activated Receptor Delta Agonist (PPAR- δ) and Selective Androgen Receptor Modulator (SARM) Abuse: Clinical, Analytical and Biological Data in a Case Involving a Poisonous Combination of GW1516 (Cardarine) and MK2866 (Ostarine)
Pascal Kintz, Laurie Gheddar, Camille Paradis, et al.
Toxics (2021) Vol. 9, Iss. 10, pp. 251-251
Open Access | Times Cited: 20
Pascal Kintz, Laurie Gheddar, Camille Paradis, et al.
Toxics (2021) Vol. 9, Iss. 10, pp. 251-251
Open Access | Times Cited: 20
Long‐term monitoring of IOX4 in horse hair and its longitudinal distribution with segmental analysis using liquid chromatography/electrospray ionization Q Exactive high‐resolution mass spectrometry for the purpose of doping control
Hideaki Ishii, Mariko Shibuya, Yat‐Ming So, et al.
Drug Testing and Analysis (2022) Vol. 14, Iss. 7, pp. 1244-1254
Closed Access | Times Cited: 12
Hideaki Ishii, Mariko Shibuya, Yat‐Ming So, et al.
Drug Testing and Analysis (2022) Vol. 14, Iss. 7, pp. 1244-1254
Closed Access | Times Cited: 12
Probing the hair detectability of prohibited substances in sports: an in vivo-in silico-clinical approach and analytical implications compared with plasma, urine, and faeces
Shao-Hsin Hung, Hung-Lin Kan, Chun-Wei Tung, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 3, pp. 779-790
Open Access | Times Cited: 2
Shao-Hsin Hung, Hung-Lin Kan, Chun-Wei Tung, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 3, pp. 779-790
Open Access | Times Cited: 2
Detection and longitudinal distribution of GW1516 and its metabolites in equine hair for doping control using liquid chromatography/high‐resolution mass spectrometry
Hideaki Ishii, Mariko Shibuya, Gary N. W. Leung, et al.
Rapid Communications in Mass Spectrometry (2021) Vol. 35, Iss. 8
Closed Access | Times Cited: 12
Hideaki Ishii, Mariko Shibuya, Gary N. W. Leung, et al.
Rapid Communications in Mass Spectrometry (2021) Vol. 35, Iss. 8
Closed Access | Times Cited: 12
Global Xenobiotic Profiling of Rat Plasma Using Untargeted Metabolomics and Background Subtraction-Based Approaches: Method Evaluation and Comparison
Xiaojuan Jiang, Simian Chen, Mingshe Zhu, et al.
Current Drug Metabolism (2023) Vol. 24, Iss. 3, pp. 200-210
Closed Access | Times Cited: 5
Xiaojuan Jiang, Simian Chen, Mingshe Zhu, et al.
Current Drug Metabolism (2023) Vol. 24, Iss. 3, pp. 200-210
Closed Access | Times Cited: 5
Development and validation of SARMs and metabolic modulators screening in hair using UHPLC-MS/MS: Application to a doping case and first identification of S23 in authentic human hair
Laurie Gheddar, Jean‐Sébastien Raul, Pascal Kintz
Journal of Chromatography B (2021) Vol. 1187, pp. 123048-123048
Open Access | Times Cited: 11
Laurie Gheddar, Jean‐Sébastien Raul, Pascal Kintz
Journal of Chromatography B (2021) Vol. 1187, pp. 123048-123048
Open Access | Times Cited: 11
Reply to the paper of Breuer et al.: complementary information concerning the suspected interindividual transmission of GW1516, a substance prohibited in sport, through intimate contact—a case report
Pascal Kintz
Forensic Toxicology (2024)
Closed Access | Times Cited: 1
Pascal Kintz
Forensic Toxicology (2024)
Closed Access | Times Cited: 1
Inhibitory Effect of PPARδ Agonist GW501516 on Proliferation of Hypoxia-induced Pulmonary Arterial Smooth Muscle Cells by Regulating the mTOR Pathway
Chang-Gui Chen, Chunfeng Yi, Chang-fa Chen, et al.
Current Medical Science (2023) Vol. 43, Iss. 5, pp. 979-987
Closed Access | Times Cited: 2
Chang-Gui Chen, Chunfeng Yi, Chang-fa Chen, et al.
Current Medical Science (2023) Vol. 43, Iss. 5, pp. 979-987
Closed Access | Times Cited: 2
Comprehensive characterization of the peroxisome proliferator activated receptor‐δ agonist GW501516 for horse doping control analysis
Stéphane Trevisiol, Yves Moulard, Vivian Delcourt, et al.
Drug Testing and Analysis (2021) Vol. 13, Iss. 6, pp. 1191-1202
Closed Access | Times Cited: 5
Stéphane Trevisiol, Yves Moulard, Vivian Delcourt, et al.
Drug Testing and Analysis (2021) Vol. 13, Iss. 6, pp. 1191-1202
Closed Access | Times Cited: 5
Interest of HRMS systems in analytical toxicology: Focus on doping products
Nadia Arbouche, Charline Bottinelli, Enrico Gerace, et al.
Annales de Toxicologie Analytique (2021) Vol. 34, Iss. 1, pp. 42-68
Open Access | Times Cited: 4
Nadia Arbouche, Charline Bottinelli, Enrico Gerace, et al.
Annales de Toxicologie Analytique (2021) Vol. 34, Iss. 1, pp. 42-68
Open Access | Times Cited: 4
Multiple prohibited ingredients detected in nutritional supplements in a case of adverse analytical finding (AAF)
Jennifer P. Pascali, Elena Piva, Pasquale Ioime, et al.
Drug Testing and Analysis (2022) Vol. 14, Iss. 10, pp. 1791-1794
Closed Access | Times Cited: 3
Jennifer P. Pascali, Elena Piva, Pasquale Ioime, et al.
Drug Testing and Analysis (2022) Vol. 14, Iss. 10, pp. 1791-1794
Closed Access | Times Cited: 3
Application of Simultaneous Analytical Methods for Selective Androgen Receptor Modulator Adulterated in Dietary Supplements Advertised as Muscle Strengthening Using UHPLC-PDA and LC–ESI–MS/MS
Nam Sook Kim, Hwan Seong Choi, Na Young Lim, et al.
Chromatographia (2022) Vol. 85, Iss. 10-11, pp. 895-919
Closed Access | Times Cited: 3
Nam Sook Kim, Hwan Seong Choi, Na Young Lim, et al.
Chromatographia (2022) Vol. 85, Iss. 10-11, pp. 895-919
Closed Access | Times Cited: 3
Hair Analysis and Doping Control
Laurie Gheddar, Pascal Kintz
Royal Society of Chemistry eBooks (2023), pp. 220-243
Closed Access | Times Cited: 1
Laurie Gheddar, Pascal Kintz
Royal Society of Chemistry eBooks (2023), pp. 220-243
Closed Access | Times Cited: 1
Effects of exercise mimetics as putative therapeutics on brain health, aging, and neurodegenerative diseases
Reza Sabzevari Rad
Sport Sciences for Health (2024) Vol. 20, Iss. 4, pp. 1207-1218
Closed Access
Reza Sabzevari Rad
Sport Sciences for Health (2024) Vol. 20, Iss. 4, pp. 1207-1218
Closed Access
Withdrawn: Liquid chromatography–tandem mass spectrometry and confirmation by liquid chromatography–high‐resolution mass spectrometry hair tests to evidence use of tizanidine by racing cyclists
Pascal Kintz, Laurie Gheddar, Jean‐Sébastien Raul
Drug Testing and Analysis (2021) Vol. 14, Iss. 1, pp. 154-161
Closed Access | Times Cited: 3
Pascal Kintz, Laurie Gheddar, Jean‐Sébastien Raul
Drug Testing and Analysis (2021) Vol. 14, Iss. 1, pp. 154-161
Closed Access | Times Cited: 3
Detection of Methylphenidate in Equine Hair Using Liquid Chromatography–High-Resolution Mass Spectrometry
Benjamin C. Moeller, L. M. Flores, Amel Clifford, et al.
Molecules (2021) Vol. 26, Iss. 19, pp. 5798-5798
Open Access | Times Cited: 3
Benjamin C. Moeller, L. M. Flores, Amel Clifford, et al.
Molecules (2021) Vol. 26, Iss. 19, pp. 5798-5798
Open Access | Times Cited: 3
Le cannabidiol est-il un produit dopant ?
Pascal Kintz
Annales de Toxicologie Analytique (2021) Vol. 33, Iss. 3, pp. 165-167
Closed Access
Pascal Kintz
Annales de Toxicologie Analytique (2021) Vol. 33, Iss. 3, pp. 165-167
Closed Access
